Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Automotive progress

18 Sep 2006 11:24

Seeing Machines Limited18 September 2006 18 September 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") SEEING MACHINES MAKES STRONG PROGRESS IN AUTOMOTIVE MARKET DRIVER FATIGUE AND DISTRACTION SYSTEM COMMENCE SECOND PHASE FIELD TRIAL Seeing Machines (AIM : SEE) announce the commencement of the second phase fieldtrial of the driver fatigue, distraction and state sensor system ("DSS") inassociation with a major oil field services and mining company in Texas, USA.In a collaborative effort with our technology commercialization partner, HellaKGaA Hueck & Co ("Hella"), Seeing Machines is testing the technology under realworld operating conditions. This second phase trial builds on the initial phase that has been run over thelast 6 months with Seeing Machines' Texan Partners. That work has inspired anumber of refinements and optimizations of the DSS-Research product that are nowbeing tested. Nick Cerneaz, CEO, Seeing Machines said: "Putting the device into the hands of afleet operator working under such harsh conditions is allowing us to iron anyremaining issues before we proceed to the general release of the product in thenear future. We are enthused with the progress of the testing to date and verymuch look forward to this next phase." The DSS-Research Product will be released in Q4 2006 and is targeted atgovernment, university and fleet manager multi-car fleet trials / research. AutocRC PrOJECT Agreement SIGNED Seeing Machines announces the execution of an agreement for research,development and commercialisation into vision based collision avoidanceapplications with the Co-operative Research Centre for Advanced AutomotiveTechnology Ltd. ("AutoCRC"). Seeing Machines had earlier agreed to become aResearch Participant in the AutoCRC, and this agreement constitutes theformation of a specific project and programme of work within that framework. The vision based collision avoidance project is a collaborative project lead bySeeing Machines and includes Latrobe University and the Australian NationalUniversity as R&D participants along with GM Holden and Australian Arrow asindustry participants. Seeing Machines will receive A$788k for work on the project through to September2008. This project is initially focused on speed sign recognition, and throughthe remainder of the AutoCRC's seven year lifespan, additional funding may bemade available to address a range of other safety issues such as pedestriandetection and integrated lane departure warning. Nick Cerneaz, CEO, Seeing Machines said "The AutoCRC is a tremendous frameworkto support the development of advanced technology that requires contributionsfrom a wide spectrum of academic, technology and commercial partners, leveragingthe best each party has to offer. The computer vision based collision avoidancesystems being developed in this program dovetail nicely with the strategies ofour own automotive business and we are consequently keen supporters of thisprogramme." The AutoCRC was established as part of the Australian Federal Government's CRCProgram initiative. For more information on the CRC Program see https://www.crc.gov.au/Information/default.aspx. For more information on the AutoCRCsee www.autocrc.com. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713 www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.